Canada · Health Canada Drug Product Database

REPLAVITE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63956
DIN
02240409
Form
Tablet
Company as listed by source
STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.
Source status
Cancelled Post Market (2002-07-31)
Source last updated
2025-03-22

Source-listed ingredients

  • VITAMIN B1 (THIAMINE MONONITRATE) — 1.5 MG — per 1 TAB
  • VITAMIN B2 (VITAMIN B2) — 1.7 MG — per 1 TAB
  • NICOTINAMIDE — 20 MG — per 1 TAB
  • FOLIC ACID — 1 MG — per 1 TAB
  • VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) — 10 MG — per 1 TAB
  • D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) — 10 MG — per 1 TAB
  • VITAMIN B12 (VITAMIN B12) — 6 MCG — per 1 TAB
  • BIOTIN — 300 MCG — per 1 TAB
  • ASCORBIC ACID (ASCORBIC ACID) — 100 MG — per 1 TAB

These values do not establish equivalence or a dose recommendation.

Packages

  • 100/500 Landmark Medical Systems Inc

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →